Welcome to this UK AstraZeneca produced and funded website
This website is intended for UK Healthcare Professionals only.
The website contains both promotional and non-promotional content.
If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk
For any other UK residents please visit astrazeneca.co.uk
This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk
For you and your patients
Symbicort® Turbohaler® Videos
To order printed copies of materials, please select the quantity you require for each resource and complete the delivery details below
You will receive a confirmation email shortly.
DPI, Dry powder lnhaler; GP, General practitioner; HCP, Healthcare professional; ICS, Inhaled Corticosteroid; LABA, Long-acting β2 agonist; MART, Maintenance and Reliever Therapy; NHS, National Health Service; pMDI, Pressurised metered dose Inhalers; Q&A, Questions and answers; SABA, Short-acting β2 agonists; SmPC, Summary of Product Characteristics.
GB-79264 | DOP: September 2026
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling 0800 783 0033.
This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.
